ZyVersa Therapeutics, Inc. - Common Stock (ZVSA)

The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

As the US market prepares to open on Wednesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.

Let's have a look at what is happening on the US markets one hour before the close of the markets on Tuesday. Below you can find the top gainers and losers in today's session.

Let's have a look at what is happening on the US markets on Tuesday. Below you can find the most active stocks in today's session.

ZyVersa gains FDA approval for emergency use of VAR 200 in a rare kidney disease case; stock jumps on high trading volume and regulatory momentum.

Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.

Wondering what's happening in Tuesday's pre-market session? Find an overview in this article.

ZyVersa's IC 100 strategy focuses on targeting inflammasome-driven inflammation to enhance weight loss and improve metabolic function in obesity patients.

Discover the top movers in Wednesday's pre-market session and stay informed about market dynamics.

Join us as we delve into today's session and uncover the stocks that are standing out with unusual volume.

In today's session, there are notable price gaps in the US markets on Wednesday. Take a closer look at the stocks that are gap up and gap down.

Curious to know what's happening on the US markets one hour before the close of the markets on Tuesday? Join us as we explore the top gainers and losers in today's session.